Biochemical Journal · 1998 · 86 citations · 35 references
MedicineBiochemistryPharmacologyCellular MetabolismDrug MetabolismMetabolismCytochrome P450 EnzymesCytochrome P450-mediated MetabolismEnzyme InductionHepatic MetabolismPorphyrin MetabolismCyp1a2 Drug MetabolismCytochrome P450 1A2Cytochrome P450 Enzyme ActivityCytochrome P450 Metabolic PathwaysCytochrome P450 PathwaysCytochrome P450 Reaction MechanismsMouse Liver MicrosomesUroporphyrinogen Metabolism
In the present study we have investigated the putative requirement for the cytochrome P-450 isoform CYP1A2 in murine uroporphyria, by comparing Cyp1a2(-/-) knockout mice with Cyp1a2(+/+) wild-type mice. Uroporphyria was produced by injecting animals with iron-dextran and giving the porphyrin precursor 5-aminolaevulinic acid in the drinking water. Some animals also received 3-methylcholanthrene (MC) to induce hepatic CYP1A2. In both protocols, uroporphyria was elicited by these treatments in the Cyp1a2(+/+) wild-type mice, but not in the null mutant mice. Uroporphyrinogen oxidation activity in hepatic microsomes from untreated Cyp1a2(+/+) mice was 2.5-fold higher than in Cyp1a2(-/-) mice. Treatment with MC increased hepatic CYP1A1 in both mouse lines and hepatic CYP1A2 only in the Cyp1a2(+/+) line, as determined by Western immunoblotting. MC increased hepatic ethoxy- and methoxy-resorufin O-dealkylase activities in both mouse lines, but increased uroporphyrinogen oxidation activity in the Cyp1a2(+/+) wild-type mice only. These results indicate the absolute requirement for hepatic CYP1A2 in causing experimental uroporphyria under the conditions used.
35